FDA found undeclared stimulants in two Addall supplements
Testing found DMAA, DMHA and phenibut. Only one product was voluntarily recalled, which leaves an uncomfortable gap between finding and removal.
Original image by Anecdotal
The FDA says Addall XR Shot and Addall XL capsules contained unlawful or undeclared ingredients. The company agreed to recall the shot but declined to recall the capsules, according to the April update.
Why this matters
The case shows why a supplement label may not reflect the actual pharmacological exposure—and why a voluntary recall can cover only part of a warning.
What testing found
FDA laboratory testing found undeclared 1,4-DMAA in both products. The shot also contained phenibut, which the agency says is not a lawful dietary-supplement ingredient, while the capsules contained DMHA.
The FDA describes cardiovascular and neurocognitive concerns associated with the ingredients and says the firm declined to recall the capsule product.
How to use the warning
This is a named-product alert, not a general statement about all energy or focus supplements. Consumers should use the FDA page for current product images and instructions because those details can change.
The broader signal is that stimulant-style supplement categories deserve ingredient-level scrutiny, particularly when marketing resembles prescription or illicit-drug effects.
What this is based on
Product-specific safety alert from the FDA.
Regulatory action · Independent
Sources
Go straight to the source.
- 01FDA Advises Consumers Not to Eat, Sell, or Distribute Addall XR Shot or Addall XLregulator
US Food and Drug Administration · 2026-04-03
Stay in the loop.
The safety & regulation stories worth opening, in one weekly email.
We never sell or share your email. Unsubscribe in one click.
Keep reading
More like this.
The moringa outbreak is over. The recalled powder may still be in cupboards.
The investigation closed at 131 reported cases across 38 states. Because the products last for years, that is not the same as the risk disappearing overnight.
FDA’s supplement import alert now covers more hidden drug ingredients
The July update reaches products sold for sexual enhancement, weight loss and muscle building—including formulas that may never make their real contents obvious.
What the UK’s new supplement guidance changes for shoppers
The June update covers authorised claims, interactions and the line supplement labels cannot cross when they talk about symptoms.